This product is free for DMNT members.
This webinar was presented live on May 26, 2021.
Treatment of Eosinophilic gastrointestinal disorders (EGID) is evolving. Our speakers will provide a Historical look at medical nutrition therapy for treatment of EGID as well as discuss updated treatment recommendations including how to organize data on the risk of cross contamination and its influence on outcomes of MNT for EGIDs. We will discuss the role of the RDN in the nutritionally driven, evidence-based treatment options and review tools to help clients improve lifestyle, diet diversity and ultimately improved quality of life.
CPE Level: 2
Performance Indicators: 4.1.2, 8.1.1, 8.3.1
- Explain Eosinophilic Gastrointestinal Disorders (EGID) as an immune mediated and chronic allergic bowel disorder amenable to dietary therapy
- Translate research findings on the role of food allergens into treatment protocols for clinicians
- Summarize the Synthesis of science and the art of medical nutrition therapy for allergic bowel disorders
Beth Doerfler, MS, RDN
Beth Doerfler is currently a Clinical Research Dietitian with Division of Gastroenterology at Northwestern Medicine in Chicago, Illinois She has authored co-authored several book chapters and journal articles on diet and lifestyle modification in gastrointestinal related diseases including several on eosinophilic gastrointestinal disease management.
Lori Welstead, MS ,RD, LDN
Lori Welstead is a Registered Dietitian with the Section of Gastroenterology, Hepatology and Nutrition at the University of Chicago Medicine. She works with a variety of patients who have gastrointestinal conditions ranging from eosinophilic gastrointestinal diseases, celiac disease, Crohn’s disease, and ulcerative colitis to irritable bowel syndrome, fatty liver disease, and obesity. She has authored articles on the various gastrointestinal diseases.